LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Characterization of Experimental and Clinical Bioaerosol Generation During Potential Aerosol-Generating Procedures.

    Doggett, Nathan / Chow, Chung-Wai / Mubareka, Samira

    Chest

    2020  Volume 158, Issue 6, Page(s) 2467–2473

    Abstract: Background: During medical procedures with the potential to produce aerosols such as bronchoscopy, intubation, or CPR, health-care workers (HCWs) may be exposed to infectious bioaerosols. This scenario is of particular concern when high consequence ... ...

    Abstract Background: During medical procedures with the potential to produce aerosols such as bronchoscopy, intubation, or CPR, health-care workers (HCWs) may be exposed to infectious bioaerosols. This scenario is of particular concern when high consequence pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are circulating. Thousands of HCWs have been infected with SARS-CoV-2. However, the determinants of aerosol generation during medical procedures and their relative risk to HCWs remain poorly characterized.
    Research question: The goal of this study was to characterize aerosols produced during airway intubation by using an uninfected translational animal model and in human subjects undergoing elective aerosol-generating procedures. The study also determined the particle size distribution of generated particles.
    Study design and methods: Aerosol generation was measured during highly controlled experimental (pig) intubations (N = 16) and elective bronchoscopies in uninfected patients (N = 49) using an optical particle counter. Recovery of normal respiratory flora was used as a surrogate for pathogen dispersion.
    Results: There was a small but significant (P = .03) decrease in 0.3 μm size particles during highly controlled pig intubations compared with baseline. The concentration of 1.0 μm and 5.0 μm aerosol particles did not significantly change, although oral bacteria were collected from the air. For elective patient bronchoscopies, there was a significant decrease in the generation of larger particles (1.0 μm and 5.0 μm) compared with baseline (P < .01); however, 18 of 39 (46%) patients showed increased aerosol production in 0.3 μm size particles, four of whom exhibited measurable increases.
    Interpretation: Although the total amount of aerosols produced during intubation and bronchoscopy did not increase significantly relative to preprocedural levels, a small number of participants exhibited a measurable increase in submicron particle emission, meriting further research to delineate determinants of fine particle production during aerosol-generating procedures.
    MeSH term(s) Aerosols ; Animals ; Biopsy ; Bronchoalveolar Lavage ; Bronchoscopy ; COVID-19/transmission ; Cough ; Elective Surgical Procedures ; Health Personnel ; Humans ; Infectious Disease Transmission, Patient-to-Professional ; Intubation, Intratracheal ; Microbiota ; Optical Devices ; Particle Size ; Particulate Matter ; Personal Protective Equipment ; Respiratory System/microbiology ; Risk ; Suction ; Swine
    Chemical Substances Aerosols ; Particulate Matter
    Keywords covid19
    Language English
    Publishing date 2020-07-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1016/j.chest.2020.07.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Coagulopathy Management of an Acute Type A Aortic Dissection in a Patient Taking Apixaban.

    Neira, Victor M / Baghaffar, Abdullah / Doggett, Nathan / Ke, Janny Xue Chen / Stewart, Keir

    Journal of cardiothoracic and vascular anesthesia

    2021  Volume 36, Issue 6, Page(s) 1720–1725

    Abstract: This paper reports the successful management of a patient with acute type A Penn B thoracic aortic dissection who was on apixaban therapy for atrial fibrillation. Emergency surgery was performed due to the patient's clinical deterioration, with ... ...

    Abstract This paper reports the successful management of a patient with acute type A Penn B thoracic aortic dissection who was on apixaban therapy for atrial fibrillation. Emergency surgery was performed due to the patient's clinical deterioration, with innominate artery compromise and severe aortic valve regurgitation. The anesthesia team used point-of-care rotational thromboelastometry-guided coagulation replacement therapy consisting of prothrombin concentrate, fibrinogen, and platelets. The surgical team used a complementary approach with topical hemostatic agents and a pericardial patch. No additional blood products were required. The patient recovered fully and was discharged home.
    MeSH term(s) Aneurysm, Dissecting/diagnostic imaging ; Aneurysm, Dissecting/surgery ; Blood Coagulation Disorders/therapy ; Humans ; Pyrazoles ; Pyridones/adverse effects ; Thrombelastography
    Chemical Substances Pyrazoles ; Pyridones ; apixaban (3Z9Y7UWC1J)
    Language English
    Publishing date 2021-03-24
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1067317-9
    ISSN 1532-8422 ; 1053-0770
    ISSN (online) 1532-8422
    ISSN 1053-0770
    DOI 10.1053/j.jvca.2021.03.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Characterization of Experimental and Clinical Bioaerosol Generation During Potential Aerosol-Generating Procedures

    Doggett, Nathan / Chow, Chung-Wai / Mubareka, Samira

    Chest

    Abstract: BACKGROUND: During medical procedures with the potential to produce aerosols such as bronchoscopy, intubation, or CPR, health-care workers (HCWs) may be exposed to infectious bioaerosols. This scenario is of particular concern when high consequence ... ...

    Abstract BACKGROUND: During medical procedures with the potential to produce aerosols such as bronchoscopy, intubation, or CPR, health-care workers (HCWs) may be exposed to infectious bioaerosols. This scenario is of particular concern when high consequence pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are circulating. Thousands of HCWs have been infected with SARS-CoV-2. However, the determinants of aerosol generation during medical procedures and their relative risk to HCWs remain poorly characterized. RESEARCH QUESTION: The goal of this study was to characterize aerosols produced during airway intubation by using an uninfected translational animal model and in human subjects undergoing elective aerosol-generating procedures. The study also determined the particle size distribution of generated particles. STUDY DESIGN AND METHODS: Aerosol generation was measured during highly controlled experimental (pig) intubations (N = 16) and elective bronchoscopies in uninfected patients (N = 49) using an optical particle counter. Recovery of normal respiratory flora was used as a surrogate for pathogen dispersion. RESULTS: There was a small but significant (P = .03) decrease in 0.3 µm size particles during highly controlled pig intubations compared with baseline. The concentration of 1.0 µm and 5.0 µm aerosol particles did not significantly change, although oral bacteria were collected from the air. For elective patient bronchoscopies, there was a significant decrease in the generation of larger particles (1.0 µm and 5.0 µm) compared with baseline (P < .01); however, 18 of 39 (46%) patients showed increased aerosol production in 0.3 µm size particles, four of whom exhibited measurable increases. INTERPRETATION: Although the total amount of aerosols produced during intubation and bronchoscopy did not increase significantly relative to preprocedural levels, a small number of participants exhibited a measurable increase in submicron particle emission, meriting further research to delineate determinants of fine particle production during aerosol-generating procedures.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #663424
    Database COVID19

    Kategorien

  4. Article ; Online: Evaluation of bioaerosol samplers for the detection and quantification of influenza virus from artificial aerosols and influenza virus-infected ferrets.

    Bekking, Christian / Yip, Lily / Groulx, Nicolas / Doggett, Nathan / Finn, Mairead / Mubareka, Samira

    Influenza and other respiratory viruses

    2019  Volume 13, Issue 6, Page(s) 564–573

    Abstract: Background: Bioaerosol sampling devices are necessary for the characterization of infectious bioaerosols emitted by naturally-infected hosts with acute respiratory virus infections. Assessment of these devices under multiple experimental conditions will ...

    Abstract Background: Bioaerosol sampling devices are necessary for the characterization of infectious bioaerosols emitted by naturally-infected hosts with acute respiratory virus infections. Assessment of these devices under multiple experimental conditions will provide insight for device use.
    Objectives: The primary objective of this study was to assess and compare bioaerosol sampling devices using a) an in vitro, environmentally-controlled artificial bioaerosol system at a range of different RH conditions and b) an in vivo bioaerosol system of influenza virus-infected ferrets under controlled environmental conditions. Secondarily, we also sought to examine the impact of NSAIDs on bioaerosol emission in influenza virus-infected ferrets to address its potential as a determinant of bioaerosol emission.
    Methods: We examined the performance of low and moderate volume bioaerosol samplers for the collection of viral RNA and infectious influenza virus in vitroand in vivo using artificial bioaerosols and the ferret model of influenza virus infection. The following samplers were tested: the polytetrafluoroethylene filter (PTFE filter), the 2-stage National Institute of Occupational Safety and Health cyclone sampler (NIOSH cyclone sampler) and the 6-stage viable Andersen impactor (Andersen impactor).
    Results: The PTFE filter and NIOSH cyclone sampler collected similar amounts of viral RNA and infectious virus from artificially-generated aerosols under a range of relative humidities (RH). Using the ferret model, the PTFE filter, NIOSH cyclone sampler and the Andersen impactor collected up to 3.66 log
    Conclusion: The PTFE filter and NIOSH cyclone sampler are useful for influenza virus RNA and infectious virus collection and may be considered for clinical and environmental settings.
    MeSH term(s) Aerosols ; Air Microbiology ; Animals ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Disease Models, Animal ; Ferrets ; Humidity ; Influenza A virus/genetics ; Influenza A virus/isolation & purification ; Orthomyxoviridae Infections/drug therapy ; Orthomyxoviridae Infections/transmission ; Orthomyxoviridae Infections/virology ; Particle Size ; RNA, Viral/analysis ; Specimen Handling/instrumentation
    Chemical Substances Aerosols ; Anti-Inflammatory Agents, Non-Steroidal ; RNA, Viral
    Keywords covid19
    Language English
    Publishing date 2019-09-21
    Publishing country England
    Document type Comparative Study ; Evaluation Study ; Journal Article
    ZDB-ID 2274538-5
    ISSN 1750-2659 ; 1750-2640
    ISSN (online) 1750-2659
    ISSN 1750-2640
    DOI 10.1111/irv.12678
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Extensive Diversity of RNA Viruses in Australian Ticks.

    Harvey, Erin / Rose, Karrie / Eden, John-Sebastian / Lo, Nathan / Abeyasuriya, Thilanka / Shi, Mang / Doggett, Stephen L / Holmes, Edward C

    Journal of virology

    2019  Volume 93, Issue 3

    Abstract: Understanding the microbiome of ticks in Australia is of considerable interest given the ongoing debate over whether Lyme disease and its causative agent, the ... ...

    Abstract Understanding the microbiome of ticks in Australia is of considerable interest given the ongoing debate over whether Lyme disease and its causative agent, the bacterium
    MeSH term(s) Animals ; Borrelia ; Genome, Viral ; Lizards ; Lyme Disease/epidemiology ; Lyme Disease/genetics ; Lyme Disease/virology ; Marsupialia ; Phylogeny ; RNA Virus Infections/genetics ; RNA Virus Infections/virology ; RNA Viruses/classification ; RNA Viruses/genetics ; RNA Viruses/isolation & purification ; Rats ; Tick-Borne Diseases/epidemiology ; Tick-Borne Diseases/transmission ; Tick-Borne Diseases/virology ; Ticks/virology
    Language English
    Publishing date 2019-01-17
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/JVI.01358-18
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance.

    Kirkman, Laura A / Zhan, Wenhu / Visone, Joseph / Dziedziech, Alexis / Singh, Pradeep K / Fan, Hao / Tong, Xinran / Bruzual, Igor / Hara, Ryoma / Kawasaki, Masanori / Imaeda, Toshihiro / Okamoto, Rei / Sato, Kenjiro / Michino, Mayako / Alvaro, Elena Fernandez / Guiang, Liselle F / Sanz, Laura / Mota, Daniel J / Govindasamy, Kavitha /
    Wang, Rong / Ling, Yan / Tumwebaze, Patrick K / Sukenick, George / Shi, Lei / Vendome, Jeremie / Bhanot, Purnima / Rosenthal, Philip J / Aso, Kazuyoshi / Foley, Michael A / Cooper, Roland A / Kafsack, Bjorn / Doggett, J Stone / Nathan, Carl F / Lin, Gang

    Proceedings of the National Academy of Sciences of the United States of America

    2018  Volume 115, Issue 29, Page(s) E6863–E6870

    Abstract: We describe noncovalent, reversible asparagine ethylenediamine (AsnEDA) inhibitors of ... ...

    Abstract We describe noncovalent, reversible asparagine ethylenediamine (AsnEDA) inhibitors of the
    MeSH term(s) Antimalarials/chemistry ; Artemisinins/chemistry ; Bortezomib/chemistry ; Drug Resistance, Microbial ; Humans ; Lactones/chemistry ; Oligopeptides/chemistry ; Plasmodium falciparum/enzymology ; Proteasome Endopeptidase Complex/chemistry ; Proteasome Inhibitors/chemistry ; Protozoan Proteins/antagonists & inhibitors ; Protozoan Proteins/chemistry
    Chemical Substances Antimalarials ; Artemisinins ; Lactones ; Oligopeptides ; Proteasome Inhibitors ; Protozoan Proteins ; Bortezomib (69G8BD63PP) ; carfilzomib (72X6E3J5AR) ; Proteasome Endopeptidase Complex (EC 3.4.25.1) ; artemisin (Y1R67R7XWU)
    Language English
    Publishing date 2018-07-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1806109115
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top